<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase I:  Electronically Actuated Low Power Microfluidic Pump</AwardTitle>
<AwardEffectiveDate>07/01/2007</AwardEffectiveDate>
<AwardExpirationDate>06/30/2008</AwardExpirationDate>
<AwardTotalIntnAmount>0.00</AwardTotalIntnAmount>
<AwardAmount>100000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Muralidharan Nair</SignBlockName>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research (SBIR) Phase I research project will develop a low-cost, low-power, and disposable microfluidic Electrolytic Hydraulic Pumps (EHPs). Many emerging diagnostic and clinical applications, such as point-of-care Polymerase Chain Reaction (PCR) pathogen analysis and ambulatory drug infusion, require battery-powered fluid pumping systems that are lightweight, low power, and extremely accurate. Unfortunately, current syringe and roller pumps are too heavy and power-hungry for many portable applications. This research will develop matchbox-sized EHPs that can pump volumes ranging from 0.1 ml to 5 ml. In addition, a programmable control system that integrates an ultrasonic transit-time flow measurement system will be developed. This combination will produce a prototype that can deliver up to 5ml volumes at 3microL/minute with a 0.1microL/minute accuracy.&lt;br/&gt;&lt;br/&gt;This technology would also permit development of high-accuracy "cigarette-pack"-sized wearable drug infusion systems. Emerging point-of-care systems analyze suspected pathogens via a PCR reaction carried out on a microfluidic chip. DNA purification and PCR reactions in the system require precise fluid delivery to ensure a reliable and repeatable pathogen analysis. The EHP Pumping system would permit design of disposable cartridges containing the pump, pre-measured reagents, and connectors. Another potential market for the proposed pumping technology would be for emerging "animal-on-a-chip" cell culturing systems and drug toxicology studies. &lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>05/24/2007</MinAmdLetterDate>
<MaxAmdLetterDate>12/06/2007</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0711986</AwardID>
<Investigator>
<FirstName>Scott</FirstName>
<LastName>Stelick</LastName>
<EmailAddress>sstelick@illuminariallc.com</EmailAddress>
<StartDate>05/24/2007</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Illuminaria, LLC</Name>
<CityName>Slaterville Springs</CityName>
<ZipCode>148819402</ZipCode>
<PhoneNumber>6075923778</PhoneNumber>
<StreetAddress>2438 Slaterville Road</StreetAddress>
<CountryName>United States</CountryName>
<StateName>New York</StateName>
<StateCode>NY</StateCode>
</Institution>
<FoaInformation>
<Code>0308000</Code>
<Name>Industrial Technology</Name>
</FoaInformation>
<ProgramElement>
<Code>5371</Code>
<Text>SBIR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>7257</Code>
<Text>APPLICATS OF ADVANCED TECHNOLS</Text>
</ProgramReference>
<ProgramReference>
<Code>9139</Code>
<Text>INFORMATION INFRASTRUCTURE &amp; TECH APPL</Text>
</ProgramReference>
<ProgramReference>
<Code>HPCC</Code>
<Text>HIGH PERFORMANCE COMPUTING &amp; COMM</Text>
</ProgramReference>
</Award>
</rootTag>
